Biosample Operations Manager
The Biosample Operations Manager will be accountable for the clinical and non-clinical sample planning, processing, tracking, reconciliation, and life-cycle management to maintain chain-of- custody in a GxP-compliant setting.
Primary Responsibilities
Manage clinical and non-clinical samples, maintain sample chain-of-custody in a GxP-compliant setting
Accountable for clinical sample logistic planning and coordination with Clinical Operations/Biomarker sub-teams, clinical sites, external labs, vendors, and couriers to define sample processing and movement timelines needed for sample testing and transfer. Oversee all operational activities required to ensure high quality sample processing, shipping, receiving, and storage
Manage external sample processing laboratories and vendors, responsible for contract development, sample preparation training, file transfer, document review, compliance monitoring and problem solving
Responsible for development and review of specialty lab manuals, SOPs, equipment methods, sample labels and other controlled documents related to sample management
Oversee clinical sample life-cycle management, responsible for innovative sample management process improvement.
Support Translational Medicine and other assay teams as needed to provide information on sample timelines and other sample related technical and operational matters.
Partner with Biomarker Lead to establish biomarker plan
Coordinate with cross-functional teams to support research sample generation and allocation
Work closely with clinical operations/CROs and/or clinical sites to resolve sample related issues in a timely manner
Responsible for receiving and registering into the biomarker LIMS system, clinical samples which will be processed in-house.
Coordinating shipments of clinical samples to off-site biobank for long term storage upon completion of internal testing.
Requirements
Required Skills
Qualifications
Pioneering Therapies for Cancer and Beyond – Our drug discovery platform is tailored to promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, undruggable proteins, in essence leading to pharmacological prote...
- Employees
- 11-50 employees
- Industry
- Biotechnology
- Total raised
- $220M raised